CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue
Operating expenses:
General and administrative (including stock-based compensation)	636,017	630,542	1,302,272	1,497,036
Depreciation	460	394	921	724
Research and development (including stock-based compensation)	7,431	15,148	15,730	43,591
Total operating expenses	643,908	646,084	1,318,923	1,541,351
Loss from operations	(643,908)	(646,084)	(1,318,923)	(1,541,351)
Other (income) expense:
Interest income	(109)	(1,375)	(504)	(3,310)
Interest expense	74,790	85,285	145,717	111,380
Total other expense	74,681	83,910	145,213	108,070
Net income (loss)	(718,589)	(729,994)	(1,464,136)	(1,649,421)
Net loss attributable to the noncontrolling interest
Net income (loss) applicable to Bion's common stockholders	$ (718,589)	$ (729,994)	$ (1,464,136)	$ (1,649,421)